Cantor Fitzgerald Upgrades Upexi (NASDAQ:UPXI) to Strong-Buy

Key Points

• Cantor Fitzgerald upgraded Upexi (NASDAQ:UPXI) to a "strong-buy," and the stock carries a consensus "Moderate Buy" with a $8.33 target despite mixed analyst views (one Strong Buy, one Buy, one Sell).
• Upexi reported a large EPS miss—($2.94) vs. ($0.08) expected—alongside a negative net margin (~496.86%) and ROE (-41.47%), and it trades near $1.04 with a ~$72M market cap, signaling substantial financial weakness and volatility.

Upexi (NASDAQ:UPXI - Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald to a "strong-buy" rating in a research note issued to investors on Thursday,Zacks.com reports.

Other equities analysts also recently issued reports about the stock. iA Financial set a $8.00 price objective on shares of Upexi in a report on Tuesday, January 13th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Upexi in a report on Monday, December 29th. Finally, Wall Street Zen downgraded shares of Upexi from a "hold" rating to a "sell" rating in a report on Saturday, January 3rd. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $8.33.

Upexi Price Performance

UPXI opened at $1.04 on Thursday. The company has a debt-to-equity ratio of 2.96, a current ratio of 2.20 and a quick ratio of 2.19. The company has a market capitalization of $72.12 million, a price-to-earnings ratio of -0.32 and a beta of -0.61. The firm's fifty day moving average price is $0.98 and its two-hundred day moving average price is $2.64. Upexi has a 1 year low of $0.54 and a 1 year high of $22.57.

Upexi (NASDAQ:UPXI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The company reported ($2.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by ($2.86). The firm had revenue of $10.96 million for the quarter, compared to analysts' expectations of $9.42 million. Upexi had a negative return on equity of 41.47% and a negative net margin of 496.86%.

Hedge Funds Weigh In On Upexi

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Ameritas Advisory Services LLC purchased a new position in shares of Upexi in the 3rd quarter worth about $26,000. Clearstead Advisors LLC purchased a new position in shares of Upexi in the 4th quarter worth about $27,000. Price T Rowe Associates Inc. MD purchased a new position in shares of Upexi in the 4th quarter worth about $35,000. Belpointe Asset Management LLC purchased a new position in shares of Upexi in the 3rd quarter worth about $58,000. Finally, Arkadios Wealth Advisors purchased a new position in shares of Upexi in the 3rd quarter worth about $58,000. 5.68% of the stock is owned by hedge funds and other institutional investors.

About Upexi

Upexi NASDAQ: UPXI is a full-service digital consultancy that partners with brands to design, develop, and deploy digital products and marketing strategies. The company's expertise spans user experience and interface design, custom software engineering, and data-driven marketing services. By integrating research, creative design, and technical execution, Upexi helps clients accelerate product development cycles and optimize their digital presence.

The firm serves a diverse, global clientele across sectors such as e-commerce, software-as-a-service (SaaS), healthcare, and finance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.